- Home
- VSEC vs CNTA Comparison
VSEC vs CNTA Comparison
Compare VSEC & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSEC
- CNTA
- Stock Information
- Founded
- VSEC 1959
- CNTA 2020
- Country
- VSEC United States
- CNTA United Kingdom
- Employees
- VSEC N/A
- CNTA N/A
- Industry
- VSEC Military/Government/Technical
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- VSEC Consumer Discretionary
- CNTA Health Care
- Exchange
- VSEC Nasdaq
- CNTA Nasdaq
- Market Cap
- VSEC 2.1B
- CNTA 2.2B
- IPO Year
- VSEC N/A
- CNTA 2021
- Fundamental
- Price
- VSEC $124.31
- CNTA $13.70
- Analyst Decision
- VSEC Strong Buy
- CNTA Strong Buy
- Analyst Count
- VSEC 6
- CNTA 9
- Target Price
- VSEC $118.67
- CNTA $25.63
- AVG Volume (30 Days)
- VSEC 250.8K
- CNTA 1.0M
- Earning Date
- VSEC 05-07-2025
- CNTA 03-24-2025
- Dividend Yield
- VSEC 0.33%
- CNTA N/A
- EPS Growth
- VSEC N/A
- CNTA N/A
- EPS
- VSEC 0.85
- CNTA N/A
- Revenue
- VSEC $1,080,132,000.00
- CNTA N/A
- Revenue This Year
- VSEC N/A
- CNTA N/A
- Revenue Next Year
- VSEC $12.06
- CNTA N/A
- P/E Ratio
- VSEC $60.01
- CNTA N/A
- Revenue Growth
- VSEC 25.53
- CNTA N/A
- 52 Week Low
- VSEC $73.36
- CNTA $7.75
- 52 Week High
- VSEC $128.72
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- VSEC 61.17
- CNTA 36.19
- Support Level
- VSEC $110.15
- CNTA $13.01
- Resistance Level
- VSEC $128.72
- CNTA $15.04
- Average True Range (ATR)
- VSEC 5.16
- CNTA 1.11
- MACD
- VSEC -0.23
- CNTA -0.30
- Stochastic Oscillator
- VSEC 76.25
- CNTA 14.81
About VSEC VSE Corporation
VSE Corp is a diversified aftermarket products and services company providing repair services, parts distribution, logistics, supply chain management and consulting services for land, sea and air transportation assets to commercial and government markets. Its operations include supply chain management solutions, parts supply and distribution, and maintenance, repair and overhaul (MRO) services for vehicle fleet, aviation, maritime and other customers. Its reportable segments are; Aviation and Fleet. Majority of the revenue for the company is generated from the Aviation segment which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business and general aviation operators.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.